KR100729015B1 - Ｎ,ｏ-아미도말로네이트 백금 착화합물 - Google Patents

Ｎ,ｏ-아미도말로네이트 백금 착화합물 Download PDF

Info

Publication number
KR100729015B1
KR100729015B1 KR1020027008709A KR20027008709A KR100729015B1 KR 100729015 B1 KR100729015 B1 KR 100729015B1 KR 1020027008709 A KR1020027008709 A KR 1020027008709A KR 20027008709 A KR20027008709 A KR 20027008709A KR 100729015 B1 KR100729015 B1 KR 100729015B1
Authority
KR
South Korea
Prior art keywords
platinum
chelate
gly
polymer
ama
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020027008709A
Other languages
English (en)
Korean (ko)
Other versions
KR20020082208A (ko
Inventor
도날드알. 스테워트
존알. 리스
존브이. 세인트.존
Original Assignee
어섹스 팔마큐티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 어섹스 팔마큐티칼스 인코포레이티드 filed Critical 어섹스 팔마큐티칼스 인코포레이티드
Publication of KR20020082208A publication Critical patent/KR20020082208A/ko
Application granted granted Critical
Publication of KR100729015B1 publication Critical patent/KR100729015B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020027008709A 2000-01-04 2001-01-04 Ｎ,ｏ-아미도말로네이트 백금 착화합물 Expired - Fee Related KR100729015B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17443500P 2000-01-04 2000-01-04
US60/174,435 2000-01-04

Publications (2)

Publication Number Publication Date
KR20020082208A KR20020082208A (ko) 2002-10-30
KR100729015B1 true KR100729015B1 (ko) 2007-06-14

Family

ID=22636134

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027008709A Expired - Fee Related KR100729015B1 (ko) 2000-01-04 2001-01-04 Ｎ,ｏ-아미도말로네이트 백금 착화합물

Country Status (8)

Country Link
US (1) US6692734B2 (enExample)
EP (1) EP1254145A1 (enExample)
JP (2) JP5025062B2 (enExample)
KR (1) KR100729015B1 (enExample)
AU (1) AU2762101A (enExample)
CA (1) CA2396702C (enExample)
WO (1) WO2001049696A1 (enExample)
ZA (1) ZA200205358B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
US7754684B2 (en) * 2003-06-11 2010-07-13 Access Pharmaceuticals, Inc. Macromolecular platinum chelates
RU2472812C2 (ru) 2005-12-05 2013-01-20 НИТТО ДЕНКО КОРПОРЭЙШН (Джэпэн/Джэпэн) Конъюгаты полиглутамат-аминокислота и способы
DK2155254T3 (da) * 2007-05-09 2013-03-04 Nitto Denko Corp Med platinlægemidler konjugerede polymere
PL2209814T3 (pl) * 2007-11-13 2017-08-31 Bio-Technology General (Israel) Ltd. Proces sterylizacji przez filtrację z rozcieńczaniem dla lepkosprężystych biopolimerów
KR101705077B1 (ko) * 2008-10-07 2017-02-09 렉산 파마슈티컬스, 인코포레이티드 Ｈｐｍａ-도세탁셀 또는 젬시타빈 컨쥬게이트 및 이의 용도
JP5281358B2 (ja) * 2008-10-27 2013-09-04 学校法人常翔学園 高分子、経上皮吸収促進剤、及び医薬用製剤
EP2488207A4 (en) 2009-10-13 2015-06-10 Rexahn Pharmaceuticals Inc POLYMERIC ANTIBODY RELEASE SYSTEMS
JP5684056B2 (ja) 2010-08-16 2015-03-11 株式会社マキタ 手持ち工具
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US10335433B2 (en) * 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
US20160220689A1 (en) * 2013-09-10 2016-08-04 Starpharma Pty Ltd. Macromolecules of dendrimer-platinum conjugates
KR20180019536A (ko) 2015-06-24 2018-02-26 니폰 가야꾸 가부시끼가이샤 신규한 백금(ⅳ) 착물
WO2017047497A1 (ja) 2015-09-14 2017-03-23 日本化薬株式会社 ６配位白金錯体の高分子結合体
EP3706801A4 (en) * 2017-11-08 2022-04-06 L.E.A.F Holdings Group LLC PLATINUM COMPLEXES AND USES THEREOF
CA3106568A1 (en) 2018-07-19 2020-01-23 Starpharma Pty Ltd Therapeutic dendrimer
US12071517B2 (en) 2018-07-19 2024-08-27 Starpharma Pty Ltd. Therapeutic dendrimer
CN113018311A (zh) * 2019-12-25 2021-06-25 沈阳药科大学 顺铂配合物以及顺铂配合物脂质体的制备方法
CN117105797B (zh) * 2023-08-25 2025-09-23 湖南科技大学 一种谷氨酸铂配合物及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028141A1 (en) * 1979-10-26 1981-05-06 Dyno Industrier A/S Building for detonating explosives
EP0028419A2 (en) * 1979-11-05 1981-05-13 Hitachi, Ltd. Imides and process for producing the same
JPH0256421A (ja) * 1988-08-19 1990-02-26 Tanabe Seiyaku Co Ltd 抗腫瘍剤
JPH0267217A (ja) * 1988-09-01 1990-03-07 Tanabe Seiyaku Co Ltd 抗腫瘍剤
US4946954A (en) * 1989-01-17 1990-08-07 Georgetown University Platinum pharmaceutical agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67789A (en) 1983-01-31 1986-09-30 Yissum Res Dev Co Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4882447A (en) 1987-02-20 1989-11-21 Tanabe Seiyaku Co., Ltd. Novel organic platinum complex and process for the preparation thereof
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
JPS6494A (en) * 1987-03-06 1989-01-05 Tanabe Seiyaku Co Ltd Novel organoplatinum complex
IL85595A0 (en) 1987-03-06 1988-08-31 Tanabe Seiyaku Co Organic platinum complex and its preparation
KR0164460B1 (ko) 1995-10-02 1999-03-20 김은영 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제
US5965118A (en) * 1997-04-18 1999-10-12 Access Pharmaceuticals, Inc. Polymer-platinum compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028141A1 (en) * 1979-10-26 1981-05-06 Dyno Industrier A/S Building for detonating explosives
EP0028419A2 (en) * 1979-11-05 1981-05-13 Hitachi, Ltd. Imides and process for producing the same
JPH0256421A (ja) * 1988-08-19 1990-02-26 Tanabe Seiyaku Co Ltd 抗腫瘍剤
JPH0267217A (ja) * 1988-09-01 1990-03-07 Tanabe Seiyaku Co Ltd 抗腫瘍剤
US4946954A (en) * 1989-01-17 1990-08-07 Georgetown University Platinum pharmaceutical agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Anti-cancer Drug Design, 1990, 5(4), 371-378.
Inorganic Chemistry, 1990, 29(25), 5125-5129.
Inorganica Chimica Acta, 1989, 161(1), 113-123.

Also Published As

Publication number Publication date
AU2762101A (en) 2001-07-16
ZA200205358B (en) 2003-08-20
JP5025062B2 (ja) 2012-09-12
EP1254145A1 (en) 2002-11-06
JP2003530317A (ja) 2003-10-14
KR20020082208A (ko) 2002-10-30
WO2001049696A1 (en) 2001-07-12
US6692734B2 (en) 2004-02-17
JP2011137046A (ja) 2011-07-14
CA2396702C (en) 2010-03-23
CA2396702A1 (en) 2001-07-12
US20010038830A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
KR100729015B1 (ko) Ｎ,ｏ-아미도말로네이트 백금 착화합물
US20070197427A1 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
US7754684B2 (en) Macromolecular platinum chelates
CN104548109B (zh) 生物医学组合物
CA2616957A1 (en) Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
US20190314446A1 (en) Vap polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor
US20170100485A1 (en) Metal-polysaccharide conjugates: methods for cancer therapy
US7005124B2 (en) Dendritic-antineoplastic drug delivery system
WO2014084378A1 (ja) 環状ｒｇｄ配列含有ペプチドを含む抗癌剤
AU2006222657B2 (en) N,O-amidomalonate platinum complexes
Pan et al. In Vivo Surface-Reactive Nanoparticles of Polypeptide-Drug Conjugates Adopt α-Helical Structures to Enhance Lysosomal Membrane Permeabilization and Anti-Tumor Efficacy
US20060039891A1 (en) Antineoplastic-dendritic polymer drug delivery system
US20130259944A1 (en) Methods and compositions for treating cancer with platinum particles
AU2012202161A1 (en) O,O'-amidomalonate and N,O-amidomalonate platinum complexes

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction

St.27 status event code: A-5-5-P10-P19-oth-PG1701

Patent document republication publication date: 20080423

Republication note text: Request for Correction Notice (Document Request)

Gazette number: 1007290150000

Gazette reference publication date: 20070614

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20120518

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20130609

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20130609

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000